HP

Hikari Power Portfolio holdings

AUM $1.2B
This Quarter Return
+12.18%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$895M
AUM Growth
+$895M
Cap. Flow
+$21M
Cap. Flow %
2.35%
Top 10 Hldgs %
70.52%
Holding
70
New
10
Increased
11
Reduced
3
Closed

Sector Composition

1 Financials 46.57%
2 Healthcare 18.39%
3 Industrials 7.55%
4 Materials 6.6%
5 Technology 4.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRU icon
51
Prudential Financial
PRU
$37.8B
$496K 0.06%
+6,350
New +$496K
MRK icon
52
Merck
MRK
$210B
$481K 0.05%
+5,880
New +$481K
BMY icon
53
Bristol-Myers Squibb
BMY
$96.7B
$463K 0.05%
+7,460
New +$463K
AVXL icon
54
Anavex Life Sciences
AVXL
$817M
$462K 0.05%
85,585
ECL icon
55
Ecolab
ECL
$77.5B
$454K 0.05%
2,100
CHL
56
DELISTED
China Mobile Limited
CHL
$414K 0.05%
14,490
-33,810
-70% -$966K
OMC icon
57
Omnicom Group
OMC
$15B
$343K 0.04%
5,500
NVCR icon
58
NovoCure
NVCR
$1.35B
$294K 0.03%
+1,700
New +$294K
GE icon
59
GE Aerospace
GE
$293B
$267K 0.03%
24,700
-25,580
-51% -$276K
TGTX icon
60
TG Therapeutics
TGTX
$5.03B
$260K 0.03%
+5,000
New +$260K
AKTX
61
Akari Therapeutics
AKTX
$21.4M
$166K 0.02%
89,815
ALDX icon
62
Aldeyra Therapeutics
ALDX
$350M
$137K 0.02%
20,020
ALPN
63
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$132K 0.01%
10,445
BDSI
64
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$105K 0.01%
25,000
AMRN
65
Amarin Corp
AMRN
$311M
$73K 0.01%
15,000
CRVS icon
66
Corvus Pharmaceuticals
CRVS
$419M
$71K 0.01%
19,959
ADMA icon
67
ADMA Biologics
ADMA
$4.03B
$59K 0.01%
30,075